DAJIAWEIKANG: The Shenzhen Stock Exchange has decided to terminate the review of the company's application for a private placement
I'm LongbridgeAI, I can summarize articles.DAJIAWEIKANG announced that it has submitted a withdrawal of its application to issue shares to specific targets for the year 2024 to the Shenzhen Stock Exchange. The Shenzhen Stock Exchange has decided to terminate the review of this application, making this decision based on the relevant rules for the issuance of securities by listed companies
According to the Zhitong Finance APP, DAJIAWEIKANG (301126.SZ) announced that on April 3, 2025, the company and its sponsor Guojin Securities Co., Ltd. submitted the application for the withdrawal of the "Application for the Issuance of Stocks to Specific Objects and Listing on the Growth Enterprise Market by Hunan DAJIAWEIKANG Pharmaceutical Industry Co., Ltd." and the "Application Report for the Withdrawal of the Application for the Issuance of Stocks to Specific Objects and Listing on the Growth Enterprise Market by Guojin Securities Co., Ltd." to the Shenzhen Stock Exchange (referred to as "SZSE"), applying to withdraw the application documents for the issuance of stocks to specific objects.
Recently, the company received the "Decision on Terminating the Review of Hunan DAJIAWEIKANG Pharmaceutical Industry Co., Ltd.'s Application for Issuing Stocks to Specific Objects" (Shenzhen Stock Exchange Review [2025] No. 46) issued by the SZSE. According to Article 20 of the "Rules for the Review of Securities Issuance and Listing of Listed Companies on the Shenzhen Stock Exchange" and Article 62 of the "Rules for the Review of Stock Issuance and Listing on the Shenzhen Stock Exchange (2024 Revision)," the SZSE decided to terminate the review of the company's application for issuing stocks to specific objects